End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | -12.50% | -12.50% | +40.00% |
02-28 | NAVCO Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,350,441 | 39,946,936 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Navco Pharmaceuticals, Inc.
1050 West Georgia Street Suite 1500
V6E 4N7, Vancouver
+
Sector
1st Jan change | Capi. | |
---|---|---|
+14.56% | 393B | |
+12.63% | 142B | |
+18.59% | 77.56B | |
-12.03% | 65.38B | |
-4.32% | 43.08B | |
+6.12% | 35.13B | |
+10.76% | 18.14B | |
+15.17% | 15.83B | |
-2.72% | 11.59B |
- Stock Market
- Equities
- NAV Stock
- NAV Stock
- Company Navco Pharmaceuticals Inc.